AI-Designed Cancer Drugs: Isomorphic Labs to Begin Human Trials
Isomorphic Labs, backed by Google's parent Alphabet, is set to begin human trials for cancer drugs designed entirely by AI, marking a pivotal moment in medicine.
posted on 07/09/2025
Isomorphic Labs, backed by Google's parent Alphabet, is set to begin human trials for cancer drugs designed entirely by AI, marking a pivotal moment in medicine.
posted on 07/09/2025
OpenAI and the FDA are collaborating on using AI to accelerate drug evaluations, potentially saving years in the process.
posted on 05/07/2025